Beam Therapeutics (BEAM) is up 11.3%, or $2.63 to $26.00.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- 3 Penny Stocks to Watch Now, 12/2/25
- Beam Therapeutics initiated with an Outperform at Evercore ISI
- Cathie Wood Cuts Stake in Pinterest Stock (PINS), Loads Up on Bitmine (BMNR) and Biotech Stocks
- Beam Therapeutics’ BEAM-101: Advancements in Sickle Cell Disease Therapy and Manufacturing Efficiency Drive Buy Rating
- FDA appoints Richard Pazdur as Director of CDER